Ignace de Hingh. Catharina Kanker Instituut. Eindhoven. North Brabant, Netherlands
Vic Verwaal. Skånes universitetssjukhus Lund. Lund, Sweden

• 09.00-09.15 – Use or misuse of neoadjuvant systemic therapy in PSM (evidence and influence on surgical indications or decisions)
  Olivia Sgarbura. Institut du Cancer de Montpellier. Montpellier, France
• 09.15-09.30 – Assessment and prognostic value of pathologic response to neoadjuvant therapy
  Frèdèric Bibeau. Centre Hospitalier Universitaire de Besançon. Marie et Louis Pasteur University. Besançon, France
• 09.30-09.45 – Response assessment by imaging studies after neoadjuvant therapy in PSM
  Clarisse Dromain. Centre Hospitalier Universitaire Vaudois. Lausanne, Switzerland
• 09.45-10.00 – Surgical tips for cytoreductive surgery after neoadjuvant therapy in PSM. (Does it change technique? What to resect?)
  Pompiliu Piso. Hospital Barmherzige Brüder. University of Regensburg. Germany
• 10.00-10.30 – Discussion